Night Eating Syndrome and Results from the First Placebo-Controlled Trial of Treatment, with the SSRI Medication, Sertraline: Implications for Clinical Practice

2007 ◽  
Vol 3 (01) ◽  
Author(s):  
John P. O'Reardon ◽  
Karen E. Groff ◽  
Albert J. Stunkard ◽  
Kelly C. Allison
Keyword(s):  
Clinical Practice ◽  
Controlled Trial ◽  
Night Eating Syndrome ◽  
Night Eating ◽  
Ssri Medication

A Randomized, Placebo-Controlled Trial of Sertraline in the Treatment of Night Eating Syndrome

2006 ◽  
Vol 163 (5) ◽  
pp. 893-898 ◽  
Author(s):  
John P. O’Reardon ◽  
Kelly C. Allison ◽  
Nicole S. Martino ◽  
Jennifer D. Lundgren ◽  
Moonseong Heo ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Night Eating Syndrome ◽  
Night Eating

scholarly journals Personality Traits and Night Eating Syndrome in Women With Bulimia Nervosa and Binge Eating Disorder

2021 ◽  
Author(s):  
Natasha D Melunsky ◽  
Francesca Solmi ◽  
Zoë Haime ◽  
Sarah Rowe ◽  
Virginia VW McIntosh ◽  
...  
Keyword(s):  
Eating Disorder ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Personality Traits ◽  
Binge Eating Disorder ◽  
Controlled Trial ◽  
Harm Avoidance ◽  
Outpatient Psychotherapy ◽  
Night Eating Syndrome ◽  
Night Eating

Abstract Purpose Evidence suggests that the harm avoidance personality type is more common among individuals with night eating syndrome (NES) than in the general population. Evidence of associations with other personality traits is limited. The current study investigated the association between a range of personality traits and NES.Methods Cross-sectional data were used from women with bulimia nervosa or binge eating disorder referred for treatment in an outpatient psychotherapy trial. Regression analyses were used to test associations between personality traits (measured with the Temperament and Character Inventory-Revised) and NES symptoms (measured with the Night Eating Questionnaire), adjusting for potential confounding variables.Results The sample included 111 women. Low cooperativeness scores were associated with greater NES symptoms in the multivariable model (mean difference: -.10, 95% confidence intervals: -.20 to -.01, p = 0.033). There was weak evidence of associations between both high harm avoidance and low self-directedness personality traits and greater NES symptoms.Conclusions The finding that low cooperativeness was associated with greater NES symptoms is novel. Further research is needed to validate its presence in those with and without comorbid eating disorders and to examine the relative change in NES, eating disorder symptoms and personality scores in treatments focusing on cooperativeness.Level of evidence Level I (randomised controlled trial, CTB/04/08/139)

Can night eating syndrome increase basal metabolic rate?

2017 ◽  
Author(s):  
Senay Topsakal ◽  
Guzin Fidan Yaylalı ◽  
Semin Melahat Fenkci
Keyword(s):  
Metabolic Rate ◽  
Basal Metabolic Rate ◽  
Night Eating Syndrome ◽  
Night Eating

Emerging Syndromes

2017 ◽  
Author(s):  
Kelly C. Allison ◽  
Jennifer D. Lundgren
Keyword(s):  
Empirical Studies ◽  
Theoretical Models ◽  
Future Research ◽  
Night Eating Syndrome ◽  
Statistical Manual ◽  
Night Eating ◽  
Diagnostic And Statistical Manual ◽  
Impairment In Functioning ◽  
Atypical Anorexia Nervosa ◽  
Comorbid Psychopathology

The Diagnostic and Statistical Manual, fifth edition, of the American Psychiatric Association (2013) has designated several disorders under the diagnosis of otherwise specified feeding and eating disorder (OSFED). This chapter evaluates three of these, night eating syndrome (NES), purging disorder (PD), and atypical anorexia nervosa (atypical AN). It also reviews orthorexia nervosa, which has been discussed in the clinical realm as well as the popular press. The history and definition for each is reviewed, relevant theoretical models are presented and compared, and evidence for the usefulness of the models is described. Empirical studies examining the disorders’ independence from other disorders, comorbid psychopathology, and, when available, medical comorbidities, are discussed. Distress and impairment in functioning seem comparable between at least three of these emerging disorders and threshold eating disorders. Finally, remaining questions for future research are summarized.

Pharmacotherapy for Eating Disorders

2017 ◽  
Author(s):  
Susan McElroy ◽  
Anna I. Guerdjikova ◽  
Nicole Mori ◽  
Paul E. Keck
Keyword(s):  
Eating Disorders ◽  
Anorexia Nervosa ◽  
Eating Disorder ◽  
Mental Disorders ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Night Eating Syndrome ◽  
Night Eating

This chapter addresses the pharmacotherapy of the eating disorders (EDs). Many persons with EDs receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. This chapter first provides a brief rationale for using medications in the treatment of EDs. It then reviews the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES). It concludes by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.

Pharmacotherapy of the Eating Disorders

2010 ◽  
pp. 416-451 ◽  
Author(s):  
Susan L. McElroy ◽  
Anna I. Guerdjikova ◽  
Anne M. O’Melia ◽  
Nicole Mori ◽  
Paul E. Keck
Keyword(s):  
Eating Disorders ◽  
Anorexia Nervosa ◽  
Eating Disorder ◽  
Mental Disorders ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Night Eating Syndrome ◽  
Night Eating

Many persons with eating disorders (EDs) receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. In this chapter, we first provide a brief rationale for using medications in the treatment of EDs. We then review the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa, binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES) and sleep-related eating disorder (SRED). We conclude by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.

Sign in / Sign up

Export Citation Format

Share Document